Describe Blood Transfusion in detail.

Indications & Products

• Blood transfusion replaces blood components lost or deficient. Whole blood is rarely used
• instead component therapy gives the specific part needed.
• Packed red cells restore oxygen-carrying capacity (for significant anaemia/haemorrhage)
• fresh frozen plasma (FFP) replaces clotting factors
• platelets treat thrombocytopenia/platelet dysfunction
• cryoprecipitate supplies fibrinogen and specific factors.

Compatibility & Cross-matching

Red cells must be ABO- and Rhesus-compatible to avoid a haemolytic reaction. Group O is the ‘universal donor’ for red cells (no A/B antigens) and group AB the universal recipient; Rh-negative blood is given to Rh-negative patients (especially women of childbearing age). Before transfusion, samples are grouped and cross-matched, and a strict bedside identity check of patient and unit is performed to prevent the commonest fatal error — giving the wrong blood.

Transfusion Trigger

Transfusion of red cells is guided by a restrictive threshold in most patients (e.g. A haemoglobin around 7–8 g/dL), balancing oxygen delivery against transfusion risks; the trigger is higher in active bleeding or significant cardiac disease. Each unit is given for a defined indication, not routinely.

The Transfusion Process & Safety Steps

Safe transfusion is as much about process as about the blood itself, because the great majority of serious incidents arise from human error rather than from the blood. The chain of safety runs from correct patient identification and labelling of the sample at the bedside, through accurate laboratory grouping and cross-matching, to a final, rigorous bedside check immediately before the unit is connected, in which the patient’s identity and the details on the unit and its compatibility label are confirmed against one another. The transfusion is then observed, particularly in its first minutes when acute reactions declare themselves, and each unit is given for a specific, documented indication rather than as a routine, so that patients are neither under- nor over-transfused.

Special Situations & the RH System

Two aspects of compatibility deserve emphasis. The Rhesus (D) system matters especially in women of childbearing potential, because a Rh-negative woman exposed to Rh-positive cells can form antibodies that cause haemolytic disease in a future Rh-positive fetus, so Rh-negative blood is given to Rh-negative recipients wherever possible. In an emergency when there is no time to cross-match, group O Rh-negative red cells can be given as the universal donor, moving to group-specific and then fully cross-matched blood as soon as it becomes available. These principles ensure that the life-saving benefit of transfusion is delivered without provoking the very reactions that compatibility testing exists to prevent.

Most fatal reactions are clerical, not immunological.

• Component therapy: packed red cells (O₂ carriage), FFP (clotting factors), platelets, cryoprecipitate (fibrinogen).
• Red cells must be ABO/Rh compatible; O = universal red-cell donor, AB = universal recipient.
• Group & cross-match; strict bedside identity check (wrong-blood is the commonest fatal error).
• Restrictive transfusion trigger (Hb ~7–8 g/dL) in most; higher with active bleeding/cardiac disease.
• Give each component for a defined indication.